Literature DB >> 21399502

Compound treatments and transportability of causal inference.

Miguel A Hernán1, Tyler J VanderWeele.   

Abstract

Ill-defined causal questions present serious problems for observational studies-problems that are largely unappreciated. This paper extends the usual counterfactual framework to consider causal questions about compound treatments for which there are many possible implementations (for example, "prevention of obesity"). We describe the causal effect of compound treatments and their identifiability conditions, with a special emphasis on the consistency condition. We then discuss the challenges of using the estimated effect of a compound treatment in one study population to inform decisions in the same population and in other populations. These challenges arise because the causal effect of compound treatments depends on the distribution of the versions of treatment in the population. Such causal effects can be unpredictable when the versions of treatment are unknown. We discuss how such issues of "transportability" are related to the consistency condition in causal inference. With more carefully framed questions, the results of epidemiologic studies can be of greater value to decision-makers.

Entities:  

Mesh:

Year:  2011        PMID: 21399502      PMCID: PMC3805254          DOI: 10.1097/EDE.0b013e3182109296

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  12 in total

1.  Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; Martha M Werler; Allen A Mitchell
Journal:  Am J Epidemiol       Date:  2002-01-15       Impact factor: 4.897

2.  When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data.

Authors:  Lauren E Cain; James M Robins; Emilie Lanoy; Roger Logan; Dominique Costagliola; Miguel A Hernán
Journal:  Int J Biostat       Date:  2010       Impact factor: 0.968

3.  On the consistency rule in causal inference: axiom, definition, assumption, or theorem?

Authors:  Judea Pearl
Journal:  Epidemiology       Date:  2010-11       Impact factor: 4.822

4.  Invited commentary: hypothetical interventions to define causal effects--afterthought or prerequisite?

Authors:  Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2005-08-24       Impact factor: 4.897

5.  The consistency statement in causal inference: a definition or an assumption?

Authors:  Stephen R Cole; Constantine E Frangakis
Journal:  Epidemiology       Date:  2009-01       Impact factor: 4.822

6.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

7.  Invited Commentary: Causal diagrams and measurement bias.

Authors:  Miguel A Hernán; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2009-09-15       Impact factor: 4.897

8.  Concerning the consistency assumption in causal inference.

Authors:  Tyler J VanderWeele
Journal:  Epidemiology       Date:  2009-11       Impact factor: 4.822

9.  Observation plans in longitudinal studies with time-varying treatments.

Authors:  Miguel A Hernán; Mara McAdams; Nuala McGrath; Emilie Lanoy; Dominique Costagliola
Journal:  Stat Methods Med Res       Date:  2008-11-26       Impact factor: 3.021

10.  Causal inference in infectious diseases.

Authors:  M E Halloran; C J Struchiner
Journal:  Epidemiology       Date:  1995-03       Impact factor: 4.822

View more
  97 in total

1.  Principal stratification and attribution prohibition: good ideas taken too far.

Authors:  Marshall Joffe
Journal:  Int J Biostat       Date:  2011-09-14       Impact factor: 0.968

2.  Imputation approaches for potential outcomes in causal inference.

Authors:  Daniel Westreich; Jessie K Edwards; Stephen R Cole; Robert W Platt; Sunni L Mumford; Enrique F Schisterman
Journal:  Int J Epidemiol       Date:  2015-07-25       Impact factor: 7.196

3.  Weight Loss and Coronary Heart Disease: Sensitivity Analysis for Unmeasured Confounding by Undiagnosed Disease.

Authors:  Goodarz Danaei; James M Robins; Jessica G Young; Frank B Hu; JoAnn E Manson; Miguel A Hernán
Journal:  Epidemiology       Date:  2016-03       Impact factor: 4.822

4.  Incidence of adult-onset asthma after hypothetical interventions on body mass index and physical activity: an application of the parametric g-formula.

Authors:  Judith Garcia-Aymerich; Raphaëlle Varraso; Goodarz Danaei; Carlos A Camargo; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2013-10-09       Impact factor: 4.897

5.  Principal stratification--uses and limitations.

Authors:  Tyler J Vanderweele
Journal:  Int J Biostat       Date:  2011-07-11       Impact factor: 0.968

6.  Generalizability of randomized trial results to target populations: Design and analysis possibilities.

Authors:  Elizabeth A Stuart; Benjamin Ackerman; Daniel Westreich
Journal:  Res Soc Work Pract       Date:  2017-07-27

7.  Improving Depression Among HIV-Infected Adults: Transporting the Effect of a Depression Treatment Intervention to Routine Care.

Authors:  Angela M Bengtson; Brian W Pence; Bradley N Gaynes; E Byrd Quinlivan; Amy D Heine; Julie K OʼDonnell; Heidi M Crane; W Christopher Mathews; Richard D Moore; Daniel Westreich; Conall OʼCleirigh; Katerina Christopoulos; Matthew J Mimiaga; Michael J Mugavero
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-01       Impact factor: 3.731

8.  Commentary: The Limits of Risk Factors Revisited: Is It Time for a Causal Architecture Approach?

Authors:  Katherine M Keyes; Sandro Galea
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

9.  Hypothetical midlife interventions in women and risk of type 2 diabetes.

Authors:  Goodarz Danaei; An Pan; Frank B Hu; Miguel A Hernán
Journal:  Epidemiology       Date:  2013-01       Impact factor: 4.822

10.  Are all biases missing data problems?

Authors:  Chanelle J Howe; Lauren E Cain; Joseph W Hogan
Journal:  Curr Epidemiol Rep       Date:  2015-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.